Jiao Xiaobing, Hu Jun, Zhu Lirong
Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Int J Gynecol Cancer. 2017 Nov;27(9):1833-1841. doi: 10.1097/IGC.0000000000001092.
The aim of this study was to find the unfavorable prognostic factors for recurrence after fertility-preserving surgery (FPS) in patients with borderline ovarian tumors (BOTs).
To perform a meta-analysis to compare the recurrence rates of BOT patients after FPS according to different prognostic factors, we searched PubMed, EMBASE, and Cochrane for observational studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated with a fixed-effects model.
We analyzed 32 studies that included 2691 BOT patients who underwent FPS, 383 patients of whom had a relapse in the follow-up. In meta-analysis, risks associated with recurrence in patients with unilateral cystectomy (OR, 2.49; 95% CI, 1.86-3.33) or serous borderline ovarian tumors (OR, 3.15; 95% CI, 1.97-5.02) were significantly increased, and there was no significantly increased OR for patients with laparoscopy compared with those with laparotomy (OR, 0.96; 95% CI, 0.57-1.60).
Unilateral cystectomy (19.4%) and serous BOTs (19.2%) are significantly associated with higher recurrence rates, and no negative impact of laparoscopy on recurrence can be demonstrated when compared with laparotomy in the meta-analysis.
本研究旨在找出卵巢交界性肿瘤(BOTs)患者保留生育功能手术(FPS)后复发的不良预后因素。
为进行一项荟萃分析,以比较根据不同预后因素行FPS后的BOT患者的复发率,我们检索了PubMed、EMBASE和Cochrane数据库以查找观察性研究。采用固定效应模型计算95%置信区间(CI)的比值比(OR)。
我们分析了32项研究,这些研究纳入了2691例行FPS的BOT患者,其中383例患者在随访中复发。在荟萃分析中,单侧囊肿切除术患者(OR,2.49;95%CI,1.86 - 3.33)或浆液性卵巢交界性肿瘤患者(OR,3.15;95%CI,1.97 - 5.02)复发相关风险显著增加,与开腹手术患者相比,腹腔镜手术患者的OR无显著增加(OR,0.96;95%CI,0.57 - 1.60)。
单侧囊肿切除术(19.4%)和浆液性BOTs(19.2%)与较高的复发率显著相关,在荟萃分析中,与开腹手术相比,未证实腹腔镜手术对复发有负面影响。